New pricing — Effective July 1, 2022 -

Amidst rising costs across all areas of our business, and aggressive attempts to implement cost savings without sacrificing quality, we announce the need to implement a cost increase starting July 1, 2022. If you have questions, please contact your sales representative.

Immunology of Infectious Diseases

Research in the immunology of infectious disease aims to understand how the cells of the immune system detect, interact, and respond to invading pathogens. Infectious diseases may be underscored by a variety of organisms including unicellular-prokaryotes (bacteria), unicellular-eukaryotes (yeast, protozoan), multicellular-eukaryotes (helminths), and viruses. The immunological response to infectious pathogens involves both innate and adaptive mechanisms. The initial innate immune response to infectious pathogens is often considered to be generic, mostly mediated by the recognition of pathogen-associated molecular patterns (PAMPS). In contrast, the protracted adaptive immune response is very specific and involves cellular and antibody dependent mechanisms.

Current State of Global Infectious Diseases

The World Health Organization (WHO) has ranked infectious diseases as the second global leading cause of fatalities. Among infectious diseases, those caused by animal to human transmission or zoonotic infections represent 60% of emerging infections worldwide. Emerging zoonotic infections are due to the appearance of new pathogens and exemplified by West Nile virusH1N1 influenzaH5N1 avian influenzaSARS-CoV, MERS-CoV and the most recent identified coronavirus strain SARS-CoV-2. Coronaviruses are enveloped positive-sense RNA viruses associated with upper respiratory infections and fatal pneumonia. SARS-CoV-2 is the identified causative agent of the coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19), which originated in Wuhan, capital of Hubei province, People's Republic of China at the end of 2019. Similar to SARS-CoV, SARS-CoV-2 relies on its Spike protein for cell entry and infection. 

SARS-CoV Spike Protein
NB100-56578

SARS Envelope Protein
NB100-56562

SARS Nucleocapsid Protein
NB100-56683


Explore Tools for COVID-19 Research


Select References

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. (2020). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology.

Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. In Coronaviruses: Methods and Protocols.

Thakur, A., Mikkelsen, H., & Jungersen, G. (2019). Intracellular pathogens: Host immunity and microbial persistence strategiesJournal of Immunology Research